Biolimus A9
-
Biolimus A9
structure -
-
CAS No:
851536-75-9
-
Formula:
C55H87NO14
-
Chemical Name:
Biolimus A9
-
Synonyms:
Rapamycin,42-O-(2-ethoxyethyl)-;42-O-(2-Ethoxyethyl)rapamycin;Biolimus A9;40-O-(2-Ethoxyethyl)rapamycin;Ba 9;TRM 986;Umirolimus;Biolimus;944472-64-4
- Categories:
-
CAS No:
Drug Information
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)|Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)
40-O-(2-ethoxyethyl)rapamycin
Biolimus A9 Use and Manufacturing
Umirolimus is a semi-synthetic macrocyclic lactone prepared from rapamycin by selective alkylation of the 42-hydroxy group, providing one of most hydrophobic tacrolimus analogues. Umirolimus has been targeted for use in stents and medical devices to suppress localised immunoreaction. Like all tacrolimus analogues, umirolimus binds to receptor protein, FKBP12. The complex then binds to mTOR and prevents it from interacting with target proteins. Umirolimus is extensively cited in the literature with over 70 citations.
Computed Properties
Molecular Weight:986.3
XLogP3:6.8
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:14
Rotatable Bond Count:11
Exact Mass:985.61265645
Monoisotopic Mass:985.61265645
Topological Polar Surface Area:194
Heavy Atom Count:70
Complexity:1840
Defined Atom Stereocenter Count:15
Defined Bond Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
2,3-Didehydro gibberellin A9
2531-21-7
-
(3R,7Z,9S,12E,14S)-14-ethyl-5-hydroxy-5-(hydroxymethyl)-7-methoxy-3,9,13-trimethyl-11-methylidene-1-oxacyclotetradeca-7,12-diene-2,4-dione
100227-57-4
-
Thiobutyrolactone
1003-10-7
-
9-[(2-methyl-4-methylidene-5-oxooxolan-2-yl)methyl]-3H-purin-6-one Formula
100682-44-8
-
6,6-ethylene-15,16-methylene-3-oxo-17-pregn-4-ene-2,17-carbolactone Formula
101765-35-9
-
nemadectin β Formula
102042-08-0
-
(5S)-3-[(2R,13R)-2,13-Dihydroxy-13-[(2R,2′R,5R,5′R)-octahydro-5′-[(1R)-1-hydroxyundecyl][2,2′-bifuran]-5-yl]tridecyl]-5-methyl-2(5H)-furanone Structure
102989-24-2
-
3-Ethyldihydro-3-methyl-2(3H)-thiophenone Structure
103620-92-4
-
What is [(3aR,4R,6Z,10Z,12R,14Z,15aR)-4-acetyloxy-6,10,14-trimethyl-3-methylidene-2-oxo-3a,4,5,8,9,12,13,15a-octahydrocyclotetradeca[b]furan-12-yl] acetate
104992-92-9
-
What is [(3aR,6Z,9R,10Z,14Z,15aS)-6,10,14-trimethyl-3-methylidene-2-oxo-3a,4,5,8,9,12,13,15a-octahydrocyclotetradeca[b]furan-9-yl] acetate
104992-93-0